Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wilhelm

Showing results (461-470 of 489) with videos related to

Pageof 49
Sort By:
Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.
Pharmacotherapy|March 31, 2012
Importance of direct patient care in advanced pharmacy practice experiences, R Chris Rathbun, E Kelly Hester, et al.
Anti-Cancer Drugs|March 10, 1998
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancerC M Kurbacher, I A Cree, H W Bruckner, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Piperidine-renin inhibitors compounds with improved physicochemical propertiesR Güller, A Binggeli, V Breu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphomaS Sasse, B Klimm, H Görgen, et al.
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Journal of Science and Medicine in Sport|December 13, 2021
Diagnostic yield and cost analysis of electrocardiographic screening in Swiss paediatric athletesM Albiński, M Saubade, A Menafoglio, et al.
Leukemia|January 6, 2007
Antitumor activity of sorafenib in FLT3-driven leukemic cellsD Auclair, D Miller, V Yatsula, et al.
International Journal of Cardiology|August 22, 2021
EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?M Scherrenberg, U Zeymer, S Schneider, et al.
Pageof 49

Showing results (461-470 of 489) with videos related to

Sort By:
Pageof 49
Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.
Pharmacotherapy|March 31, 2012
Importance of direct patient care in advanced pharmacy practice experiences, R Chris Rathbun, E Kelly Hester, et al.
Anti-Cancer Drugs|March 10, 1998
Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancerC M Kurbacher, I A Cree, H W Bruckner, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Piperidine-renin inhibitors compounds with improved physicochemical propertiesR Güller, A Binggeli, V Breu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphomaS Sasse, B Klimm, H Görgen, et al.
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Journal of Science and Medicine in Sport|December 13, 2021
Diagnostic yield and cost analysis of electrocardiographic screening in Swiss paediatric athletesM Albiński, M Saubade, A Menafoglio, et al.
Leukemia|January 6, 2007
Antitumor activity of sorafenib in FLT3-driven leukemic cellsD Auclair, D Miller, V Yatsula, et al.
International Journal of Cardiology|August 22, 2021
EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?M Scherrenberg, U Zeymer, S Schneider, et al.
Pageof 49